Global Regulatory Pathways for Drugs and Biologics

New program provides path to pharmaceutical education. * 14 hrs ago Keck Graduate Institute and Glendale Community College have announced a new partnership designed to expand access to pharmacy education through KGI's CC to PharmD pathway. The agreement creates a clear and supportive route for GCC students to transition into KGI's Doctor of Pharmacy program, or PharmD, beginning this fall, helping students save money and time on their way to their career as a pharmacist. "This partnership reflects our commitment to creating accessible, high-impact pathways for students who know they want to be pharmacists to begin their journey sooner," said Derick Han, Keck professor of biopharmaceutical sciences and interim dean of KGI's School of Pharmacy. "By working closely with Glendale Community College, we are expanding opportunities for students while strengthening the pipeline of future pharmacists prepared to lead in an evolving healthcare landscape." Through this pathway, GCC students gain access to a range of admissions and financial benefits. Eligible students who meet KGI's requirements and achieve a cumulative GPA of 3.0 will receive a transfer admission guarantee (TAG) to the PharmD program. Students with a GPA of 3.5 or higher may also qualify for a TAG scholarship of up to $20,000. Additional benefits include an application fee waiver, expedited application review, and access to select KGI summer programs. "We are excited to open this pathway for students to achieve meaningful careers in pharmacy and healthcare. For students who already see themselves serving patients and communities as pharmacists, this partnership with KGI makes that goal more accessible and attainable," said Jeremy Talaoc, GCC Dean of Science, Technology, Engineering and Math. "By beginning at GCC, students can complete key prerequisite coursework while receiving the guidance and support they need to take the next step into KGI's PharmD program." Students can learn more about the pathway and available opportunities by visiting KGI's CC to PharmD webpage at kgi.edu/future-students/cc-to-pharmd.

Terasaki Institute and Keck Graduate Institute launch partnership to advance biomedical innovation. New collaboration expands interdisciplinary research, shared facilities, and graduate training opportunities in the life sciences Terasaki Institute for Biomedical Innovation Los Angeles, CA - March 9, 2026 - The Terasaki Institute for Biomedical Innovation (TIBI) and Keck Graduate Institute (KGI) have announced a new collaborative research partnership designed to accelerate biomedical innovation through joint research programs, faculty collaboration, and expanded student training opportunities. The agreement establishes a framework for long-term collaboration between the two Southern California institutions, enabling interdisciplinary research initiatives, reciprocal faculty affiliations, shared laboratory infrastructure, and expanded educational programs. The collaboration will support research across multiple areas of biomedical innovation, including biomaterials, cell engineering, drug delivery technologies, medical devices, and personalized medicine. "This partnership reflects our shared commitment to advancing scientific discovery through collaboration," said Stewart Han, President of the Terasaki Institute for Biomedical Innovation. "By combining the complementary expertise of our institutions, we can accelerate the development of technologies that improve patient care while providing meaningful research opportunities for students and scientists." The partnership will allow researchers from both institutions to pursue joint grant proposals, collaborative research projects, and co-authored publications. Scientists will also gain reciprocal access to specialized research infrastructure, including laboratory space, core instrumentation, libraries, and animal research facilities. The collaboration will also create new opportunities for PhD student training and mentorship. KGI doctoral students will have the opportunity to conduct research in Terasaki Institute laboratories under the supervision of principal investigators, strengthening hands-on research training and interdisciplinary collaboration. "Collaborative partnerships are essential to advancing innovation in the life sciences," said Dr. Loren Martin, Associate Vice Provost of Research, Innovation, and Partnerships at Keck Graduate Institute. "Working with the Terasaki Institute will expand opportunities for our faculty and students to engage in impactful research while strengthening the connection between discovery and real-world application." The institutions will also collaborate on scientific symposia, speaker series, and summer research programs for undergraduate and high school students. The partnership will be guided by a joint Collaborative Research Steering Committee, which will coordinate research initiatives, identify funding opportunities, and evaluate progress of the collaboration. The agreement will initially run for three years, with the potential for renewal as new research programs develop. About the Terasaki Institute for Biomedical Innovation The Terasaki Institute for Biomedical Innovation is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute aims to enhance the quality of human life through translational research and the acceleration of biomedical innovation. TIBI's research focuses on the development of biomaterials, cellular and tissue engineering, medical devices, and microfluidic systems. About Keck Graduate Institute A proud member of The Claremont Colleges, Keck Graduate Institute (KGI) offers innovative master's and doctoral programs in critical high-growth areas to directly address industry needs in biotechnology and healthcare. KGI is dedicated to educating and empowering the ethical innovative leaders in biotechnology, healthcare, and life sciences who will heal and uplift communities locally and beyond. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.